IP Library › Assignment 025672/0410
Patent Assignment
Reel/Frame 025672/0410

Assignment of Assignor's Interest

Recorded: 2011-01-20 Pages: 8
Assignor
Assignees
GREENOVATION BIOTECH GMBH
BOETZINGER STR. 29B, FREIBURG, 79111, GERMANY
VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
BRUNNER STRASSE 69/OBJEKT 3, WIEN, 1230, AUSTRIA
Covered Property (1)
Method of Treating Lewis Y-Expressing Tumors
Patent: 8,323,650 →
Application: 12/786,378 →
Publication: US 2011/0020331
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 4, 2010
From: SCHUSTER, MANFRED; HIMMLER, GOTTFRIED; WAXENECKER, GUENTER; MUDDE, GEERT C.
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024489/0676 →
Certificate of Appointment Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 025671/0795 →
Change of Name Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →
Assignment of Assignor's Interest Jan 20, 2011
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 025672/0418 →
Assignment of Assignor's Interest Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 026329/0262 →
Consulting Agreement Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 025722/0761 →